Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Marksans Pharma Ltd (MARK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
161.90 -4.05    -2.44%
05:14:33 - Real-time Data. Currency in INR ( Disclaimer )
  • Volume: 459,717
  • Bid/Ask: 161.85 / 161.95
  • Day's Range: 160.05 - 166.85
Type:  Equity
Market:  India
ISIN:  INE750C01026 
S/N:  MARKSANS
Marksans Pharma Ltd 161.90 -4.05 -2.44%

NS:MARK Financials

 
This summary provides an overview of the most significant critical numbers from each of the Marksans Pharma Ltd financial reports, including theMarksans Pharma Ltd income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NS:MARK financials over time via breakdowns of their annual reports.

Marksans Pharma Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 5,312.36 million compared to INR 4,525.65 million a year ago. Revenue was INR 5,502.32 million compared to INR 4,667.18 million a year ago. Net income was INR 835.18 million compared to INR 612.53 million a year ago. Basic earnings per share from continuing operations was INR 1.84 compared to INR 1.52 a year ago. Diluted earnings per share from continuing operations was INR 1.84 compared to INR 1.52 a year ago.For the six months, sales was INR 10,312.69 million compared to INR 8,863.33 million a year ago. Revenue was INR 10,503.61 million compared to INR 9,169.85 million a year ago. Net income was INR 1,521.76 million compared to INR 1,209.68 million a year ago. Basic earnings per share from continuing operations was INR 3.36 compared to INR 2.99 a year ago. Diluted earnings per share from continuing operations was INR 3.36 compared to INR 2.99 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

MARK Income Statement & Profits

Gross margin TTM 50.99%
Operating margin TTM 18.62%
Net Profit margin TTM 15.04%
Return on Investment TTM 17.78%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 5861.27 5312.36 5000.33 4859.76
Gross Profit 3133.08 2785.17 2572.73 2421.35
Operating Income 1110.19 963.98 883.06 956.05
Net Income 832.35 835.18 827.1

MARK Balance Sheet

Quick Ratio MRQ 3.34
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 5.92%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 23135.75 21903.89
Total Liabilities 4165.63 4253.17
Total Equity 18970.12 17650.72

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 5.58
Revenue/Share TTM 46.42
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MARK Price Commentary

Write your thoughts about Marksans Pharma Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Neville Sequeira
Neville Sequeira Jan 28, 2024 23:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hold or sell? entered at 140
balakrishnaiah viswanadham
balakrishnaiah viswanadham Jan 28, 2024 23:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hold for long-term
Debabrata Choudhury
Debabrata Choudhury Jul 01, 2023 21:21
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dividend kob se start hoga
subhash mundotia
subhash mundotia Feb 21, 2023 8:17
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2x is good target price??
Mudassar Khan
Mudassar Khan Feb 03, 2023 4:13
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good for 2 years
Paramjit Lamba
Paramjit Lamba Aug 13, 2021 8:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good price for a BUY. Will shoot above 82 - 85 in a week to ten day's time.
Pawan Pandey
Pawan Pandey Jul 06, 2021 5:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is right time to for purchasing
HARSHWARDHAN NAGDEV
HARSHWARDHAN NAGDEV Jun 14, 2021 6:44
Saved. See Saved Items.
This comment has already been saved in your Saved Items
big targets don't sell
Arun Kumar
Arun Kumar May 01, 2021 17:17
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hold or sell now?Target at May end?Pls suggest...
Jayesh Bhojak
Jayesh Bhojak May 01, 2021 17:17
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hold it it will cross tgt 80.80, 87 and 92
Arun Kumar
Arun Kumar May 01, 2021 17:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hold or sell now?Target at May end?Pls suggest...
Ram Gopal Kumar Gahlot
Ram Gopal Kumar Gahlot Oct 10, 2020 8:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
long term investment
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email